glp 1 agonists GLP-1 receptor show promise in treating substance use disorders GLP-1 Agonists Market Exclusive Research
Description
What is Akkermansia muciniphila
The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease
There are no large trials proving safety, but early data suggests milk transfer is low
This systematic review evaluates the literature on the relationship between GLP-1 RA use and increased regurgitation and aspiration events to contextualize the existing, consensus-based guidelines put forth by the ASA in light of limited comparative evidence
Randomized controlled trials (RCTs) comparing insulin with established GLP-1 RAs, DPP-4is, or SGLT-2is were included
